These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18158148)

  • 1. Thermodynamic analysis does not allow discrimination of agonists and antagonists at human CCK2S-receptors.
    Harper EA; Mitchell EA; Griffin EP; Kalindjian SB
    Eur J Pharmacol; 2008 Feb; 581(1-2):1-12. PubMed ID: 18158148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic analysis of ligands at cholecystokinin CCK2 receptors in rat cerebral cortex.
    Harper EA; Roberts SP; Kalindjian SB
    Br J Pharmacol; 2007 Aug; 151(8):1352-67. PubMed ID: 17592503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological comparison of the alternatively spliced short and long CCK2 receptors.
    Morton MF; Harper EA; Tavares IA; Shankley NP
    Br J Pharmacol; 2003 Sep; 140(1):218-24. PubMed ID: 12967952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors.
    Merighi S; Simioni C; Gessi S; Varani K; Borea PA
    Biochem Pharmacol; 2010 Feb; 79(3):471-7. PubMed ID: 19766600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors.
    Varani K; Surprenant A; Vincenzi F; Tosi A; Gessi S; Merighi S; Borea PA
    Biochem Pharmacol; 2008 Mar; 75(5):1198-208. PubMed ID: 18076867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour.
    Gessi S; Fogli E; Sacchetto V; Varani K; Merighi S; Leung E; Lennan SM; Borea PA
    Biochem Pharmacol; 2008 Jan; 75(2):562-9. PubMed ID: 17936250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of binding enthalpy and entropy to affinity of antagonist and agonist binding at human and guinea pig histamine H(1)-receptor.
    Wittmann HJ; Seifert R; Strasser A
    Mol Pharmacol; 2009 Jul; 76(1):25-37. PubMed ID: 19346300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid CB1 and cholecystokinin CCK2 receptors modulate, in an opposing way, electrically evoked [3H]GABA efflux from rat cerebral cortex cell cultures: possible relevance for cortical GABA transmission and anxiety.
    Antonelli T; Tomasini MC; Mazza R; Fuxe K; Gaetani S; Cuomo V; Tanganelli S; Ferraro L
    J Pharmacol Exp Ther; 2009 May; 329(2):708-17. PubMed ID: 19197005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological analysis of CCK2 receptors up-regulated using engineered transcription factors.
    Morton MF; Liu PQ; Reik A; de la Rosa R; Mendel M; Li XY; Case C; Pabo C; Moreno V; Pyati J; Shankley NP
    Regul Pept; 2005 Jul; 129(1-3):227-32. PubMed ID: 15927720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of 1,3,4-benzotriazepine-based CCK(2) antagonists to obtain potent, orally active inhibitors of gastrin-mediated gastric acid secretion.
    McDonald IM; Black JW; Buck IM; Dunstone DJ; Griffin EP; Harper EA; Hull RA; Kalindjian SB; Lilley EJ; Linney ID; Pether MJ; Roberts SP; Shaxted ME; Spencer J; Steel KI; Sykes DA; Walker MK; Watt GF; Wright L; Wright PT; Xun W
    J Med Chem; 2007 Jun; 50(13):3101-12. PubMed ID: 17536796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamic descriptors, profiles and driving forces in membrane receptor-ligand interactions.
    Pliska V
    J Recept Signal Transduct Res; 2010 Dec; 30(6):454-68. PubMed ID: 20923252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors.
    Gilli P; Gilli G; Borea PA; Varani K; Scatturin A; Dalpiaz A
    J Med Chem; 2005 Mar; 48(6):2026-35. PubMed ID: 15771445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists.
    Buck IM; Black JW; Cooke T; Dunstone DJ; Gaffen JD; Griffin EP; Harper EA; Hull RA; Kalindjian SB; Lilley EJ; Linney ID; Low CM; McDonald IM; Pether MJ; Roberts SP; Shankley NP; Shaxted ME; Steel KI; Sykes DA; Tozer MJ; Watt GF; Walker MK; Wright L; Wright PT
    J Med Chem; 2005 Nov; 48(22):6803-12. PubMed ID: 16250639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-(tryptophylamino)-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based cholecystokinin receptor antagonists: reversal of CCK1 receptor subtype selectivity toward CCK2 receptors.
    Muñoz-Ruiz P; García-López MT; Cenarruzabeitia E; Del Río J; Dufresne M; Foucaud M; Fourmy D; Herranz R
    J Med Chem; 2004 Oct; 47(21):5318-29. PubMed ID: 15456276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists.
    Low CM; Buck IM; Cooke T; Cushnir JR; Kalindjian SB; Kotecha A; Pether MJ; Shankley NP; Vinter JG; Wright L
    J Med Chem; 2005 Nov; 48(22):6790-802. PubMed ID: 16250638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Order changes within receptor systems upon ligand binding: receptor tightening/oligomerisation and the interpretation of binding parameters.
    Williams DH; O'Brien DP; Sandercock AM; Stephens E
    J Mol Biol; 2004 Jul; 340(2):373-83. PubMed ID: 15201058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can thermodynamic measurements of receptor binding yield information on drug affinity and efficacy?
    Borea PA; Dalpiaz A; Varani K; Gilli P; Gilli G
    Biochem Pharmacol; 2000 Dec; 60(11):1549-56. PubMed ID: 11077036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel, achiral 1,3,4-benzotriazepine analogues of 1,4-benzodiazepine-based CCK(2) antagonists that display high selectivity over CCK(1) receptors.
    McDonald IM; Austin C; Buck IM; Dunstone DJ; Griffin E; Harper EA; Hull RA; Kalindjian SB; Linney ID; Low CM; Pether MJ; Spencer J; Wright PT; Adatia T; Bashall A
    J Med Chem; 2006 Apr; 49(7):2253-61. PubMed ID: 16570921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achiral, selective CCK2 receptor antagonists based on a 1,3,5-benzotriazepine-2,4-dione template.
    Spencer J; Gaffen J; Griffin E; Harper EA; Linney ID; McDonald IM; Roberts SP; Shaxted ME; Adatia T; Bashall A
    Bioorg Med Chem; 2008 Mar; 16(6):2974-83. PubMed ID: 18289857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor binding thermodynamics at the neuronal nicotinic receptor.
    Borea PA; Varani K; Gessi S; Merighi S; Dal Piaz A; Gilli P; Gilli G
    Curr Top Med Chem; 2004; 4(3):361-8. PubMed ID: 14754451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.